Catalyst Wire Dossier Catalyst Wire Dossier

ENSKYCE

Desogestrel and Ethinyl Estradiol · Lupin Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for ENSKYCE, covering 2013-03-07 to 2022-04-29. Get the full timeline:

Most recent: FDA Approved: ENSKYCE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

See pricing